BOS 0.00% 1.5¢ biosignal limited

patience, page-3

  1. 869 Posts.
    lightbulb Created with Sketch. 24
    It will be a relief to hear BOS has dealt with the protein deposition problem on the lens. It is taking some time so I guess it is a decent challenge. I hope it can be conquered, like the lens wetability problem earlier. I guess we can only wait and wish them the best.

    I am noticing a lot of researchers getting into the biofilm business. With some making claims of success. BOS still seems to be more advanced in development than the competition, but it still hinges on having a compound that works.

    An interesting site is:

    http://www.biofilmsonline.com

    (there are probably many other similar sites)

 
watchlist Created with Sketch. Add BOS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.